Publications by authors named "Zuo Shi"

Claim this Profile
A
AGR2 suppresses ferroptosis via the p53/FPN1 regulatory axis and drives therapeutic vulnerabilities in pancreatic cancer.
Ziying Jian, Jialin Song, Liangqi Lu, Tao Pan, Hanzhe Zhang, Naipeng Shi, Shi Zuo

Cell Death Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL27RA promotes the proliferation and metastasis of hepatocellular carcinoma cells by regulating TGFβR1.
YiJie Zhang, Yingxia Wu, Qiyong Zhang, Jianbin Xiong, Benli Xiao, Shi Zuo

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-gene CRISPR/cas9 library screen revealed targeting STAT6 increased the sensitivity of liver cancer to celecoxib via inhibiting arachidonic acid shunting.
Chujiao Hu, Zhirui Zeng, Xin Bao, Dahuan Li, Huading Tai, Shi Zuo

Cell Commun Signal· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study on the probabilistic characteristics of forces in the support structure of heliostat array based on the DBO-BP algorithm.
Haiyin Luo, Qiwei Xiong, Xuewen Zhang, Shi Zuo

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterial extracellular vesicles: emerging mediators of gut-liver axis crosstalk in hepatic diseases.
Yutong Zhou, Yong Sun, Pengsheng Yin, Shi Zuo, Haiyang Li

Front Cell Infect Microbiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIA3 promotes the degradation of GSH (glutathione) by binding to CHAC1, thereby promoting the progression of hepatocellular carcinoma.
Zhou Wanbiao, Man Jing, Zuo Shi, Chen Tengxiang, Zhao Xueke

Mol Cell Biochem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Type of Lenvatinib Resistance on Prognosis and Second-Line Regimen in Patients with Virus-Associated HCC.
Yijie Zhang, Jin Lei, Huaxing Ma, Shi Zuo

J Hepatocell Carcinoma· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcription factor KLF9 inhibits the proliferation, invasion, and migration of pancreatic cancer cells by repressing KIAA1522.
Yuting Guo, She Tian, Haiyang Li, Shi Zuo, Chao Yu

Asia Pac J Clin Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CARMIL1 regulates liver cancer cell proliferation by activating the ERK/mTOR pathway through the TRIM27/p53 axis.
Yuzhen Ge, Benli Xiao, Rui Zhao, Bo Li, Sibo Yang, Shi Zuo

Int Immunopharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydroartemisinin eliminates senescent cells by promoting autophagy-dependent ferroptosis via AMPK/mTOR signaling pathway.
Xing Wan, Can Li, Yue Hao Tan, Shi Qi Zuo, Feng Mei Deng

Cell Biol Int· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAP1L1 regulates BIRC2 ubiquitination modification via E3 ubiquitin ligase UBR4 and hence determines hepatocellular carcinoma progression.
Shi-Long Zhang, Shen-Jie Zhang, Lian Li, Ye-Wei Zhang, Zhi Wang, Shi Zuo

Cell Death Discov· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MULTIPLE MACHINE LEARNING METHODS AND COMPARATIVE TRANSCRIPTOMICS IDENTIFY PIVOTAL GENES FOR ISCHEMIA-REPERFUSION INJURY IN HUMAN DONOR TISSUE UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION.
Chengxin Chen, Qiang Wang, Zhe Yang, Shi Zuo, Kun Cao

Shock· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient receptor potential-related risk model predicts prognosis of hepatocellular carcinoma patients.
Xiao-Cai Mei, Qian Chen, Shi Zuo

World J Gastrointest Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAP1L5 facilitates pancreatic ductal adenocarcinoma progression via TRIM29-mediated ubiquitination of PHLPP1.
Benli Xiao, Yuzhen Ge, Rui Zhao, Yewei Zhang, Yi Guo, Shilong Zhang, Shi Zuo

Biochem Pharmacol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells.
Xiaoqiang Gao, Shi Zuo

Clin Exp Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the deubiquitinase for malignant tumor therapy (Review).
Shilong Zhang, Yi Guo, Shenjie Zhang, Zhi Wang, Yewei Zhang, Shi Zuo

Oncol Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global research trends on the links between intestinal microbiota and liver diseases: a bibliometric analysis.
Qiang Wang, Cheng-Xin Chen, Shi Zuo, Kun Cao, Hai-Yang Li

Am J Transl Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TANGO1 interacts with NRTN to promote hepatocellular carcinoma progression by regulating the PI3K/AKT/mTOR signaling pathway.
Jing Man, Wanbiao Zhou, Shi Zuo, Xueke Zhao, Qiang Wang

Biochem Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma in the real world: a single-arm meta-analysis.
Xiaoqiang Gao, Rui Zhao, Huaxing Ma, Shi Zuo

BMC Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy.
Qiang Wang, Chengxin Chen, Shi Zuo, Kun Cao, Haiyang Li

J Transl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors.
Jin Lei, Tao Yan, Linzhi Zhang, Bowen Chen, Jiamin Cheng, Shi Zuo

Hepatol Int· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of 3-year recurrence rate of hepatocellular carcinoma after resection based on contrast-enhanced CT: a single-centre study.
Chao Lv, Nan He, Jie Jie Yang, Jing Jing Xiao, Yan Zhang, Shi Zuo

Br J Radiol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC.
Si-Bo Yang, Zi-Han Zhou, Jin Lei, Xiao-Wen Li, Qian Chen, Shi Zuo

Biol Direct· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma.
Jin Lei, Sibo Yang, Bowen Chen, Linzhi Zhang, Tao Yan, Shi Zuo

J Hepatocell Carcinoma· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TKI or TKI combined with PD-1 inhibitors as second-line treatment for HCC patients after sorafenib failure.
Jin Lei, Bowen Chen, Meiru Song, Linzhi Zhang, Xinfeng Zhang, Shi Zuo

Front Pharmacol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis